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Objective: To examine the 1-year alterations of the
blood-retinal barrier and changes in retinal thickness oc-
curring in the macular region in patients with type 2 dia-
betes mellitus and mild nonproliferative retinopathy.
Methods: We classified 12 eyes of 12 patients with type
2 diabetes mellitus and mild nonproliferative retinopathy
by 7-field stereoscopic fundus photography, levels 20 and
35 of Wisconsin grading, and examined them 3 times, at
6-month intervals, by fluorescein angiography, retinal leak-
age analyzer (RLA) ( modified confocal scanning laser oph-
thalmoscope), and retinal thickness analyzer. The maps of
retinal leakage and retinal thickness were aligned and in-
tegrated into one image. Data from the group of individu-
als with diabetes were compared with those from a healthy
control population (n=14; mean age, 48 years; age range,
42-55 years) to establish reference maps for the RLA and
the retinal thickness analyzer.
Results: Areas of abnormally increased fluorescein so-
dium leakage and increased thickness were detected in
all eyes examined at baseline. The sites of increased fluo-
rescein leakage reached values as high as 483% above nor-
mal, but in 10 of the total 36 examinations performed,
fluorescein leakage returned to normal levels. A statis-
tically significant correlation was found between changes
in hemoglobin A1c values and variations in percentage of
abnormal fluorescein leakage between the 6- and 12-
month examinations (P.001). When comparing the
RLA-leaking sites among the 3 examinations, a good cor-
relation was seen among the location of these sites of maxi-
mum leakage, but there was a clear fluctuation in the per-
centage of increases. A correlation was noted between the
location of the RLA-leaking sites and the location of ar-
eas of increased retinal thickness in subsequent exami-
nations, either 6 or 12 months later. Microaneurysms
showed relatively little leakage and leaked progressively
less in successive examinations.
Conclusions: The dominant alteration in the retina of
patients with type 2 diabetes mellitus and mild nonpro-
liferative retinopathy is the presence of RLA-leaking sites,
indicating spotty retinal vascular damage characterized
by alteration of the blood-retinal barrier. This damage ap-
pears to be reversible and directly associated with varia-
tions in glycemic metabolic control. Retinal edema ap-
pears to develop mainly as a result of retinal vascular
leakage.
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R ETINOPATHY IS the most fre-quent microvascular com-plication of diabetes melli-tus. It is estimated to be themost common cause of new
cases of blindness among adults aged 20 to
74 years.1 The magnitude of the problem
becomes apparent when one realizes the
projected growth of the incidence of dia-
betes mellitus and the limitations of pho-
tocoagulation, the only tested form of
therapy, which is performed when disease
progress is already irreversible.2
To prevent and improve the treat-
ment of diabetic retinopathy, it is fun-
damental to know the evolution of the
earliest changes that occur in the dia-
betic retina and how they relate to the
progression of the retinopathy.
The accepted methods to assess reti-
nopathy are based on visual acuity changes
and findings noted on fundus photogra-
phy.3 Both provide information on late
changes but are not useful for identifying
initial alterations. The only features that
are visible on fundus photography are
microaneurysms, hemorrhages, cotton-
wool spots, hard exudates, venous abnor-
malities, and neovascularization. Exami-
nation of the initial alterations in diabetic
retinal disease must involve other meth-
ods, such as measuring alterations of the
blood-retinal barrier (BRB) and changes
in retinal thickness. Methods of multimo-
dal imaging of the ocular fundus have
recently been developed by combining in-
formation obtained from different sources,
such as fundus photography and fluores-
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cein angiography, with measurements obtained with in-
strumentation, such as the retinal leakage analyzer (RLA)
and the retinal thickness analyzer (RTA).4-6 To our knowl-
edge, we provide the results of the first 1-year follow-up
study of changes occurring in the macular region of eyes
from patients with type 2 diabetes mellitus and mild non-
proliferative retinopathy.
RESULTS
The results are summarized in the Table. Areas of ab-
normally increased fluorescein leakage were detected in
all eyes examined at baseline.
Retinal leakage analyzer–leaking sites, that is, sites
of maximal fluorescein leakage for each area of abnor-
mally increased leakage, reached values as high as 483%
above normal, but in 10 of the 36 examinations per-
formed, the fluorescein leakage returned to normal
levels. This finding occurred in 5 eyes 6 months after
inclusion in the study and in another 3 eyes at the
12-month examination.
Of the 12 patients included in the study, 8 im-
proved in metabolic control during the second period of
follow-up, that is, between the 6- and 12-month exami-
nations, and the correlation between changes in HbA1c
values and decreases or increases in percentage of ab-
normal fluorescein leakage was statistically significant
(P.001). A direct correlation between these 2 vari-
ables was present in 10 of the 12 eyes. No correlations
were found between systolic or diastolic blood pressure
PATIENTS AND METHODS
PATIENTS
Twelve eyes from 12 patients (4 men and 8 women), aged
44 to 63 years (mean±SD, 55±5 years), with type 2 diabe-
tes mellitus and mild nonproliferative retinopathy charac-
terized on 7-field stereoscopic fundus photography (SFP),
levels 20 and 35 of Wisconsin grading,2 were examined 3
times by SFP, fluorescein angiography, RLA (Zeiss,
Oberkochen, Germany), and RTA (Talia Technology, Ltd,
Mevaseret Zion, Israel) at 6-month intervals during a
1-year period. All patients had a corrected visual acuity of
20/20. The study eye was chosen as the one fulfilling the
inclusion criteria (levels 20 and 35 of Wisconsin grading).
When both eyes met the inclusion criteria, the right eye
was chosen.
The patients were followed up by the same diabetolo-
gist and remained within limits of acceptable good medi-
cal control. Their hemoglobin A1c (HbA1c) values ranged
from 5.4% to 9.7% (given as the percentage of total hemo-
globin), and their duration of diabetes ranged from 2 to 15
years (Table).
The tenets of the Declaration of Helsinki were fol-
lowed, and approval of the institutional review board was
obtained for this study. Informed consent was obtained from
the patients before they were enrolled in the study.
METHODS
Stereoscopic Fundus Photography
Stereoscopic fundus photography was performed accord-
ing to the Early Treatment Diabetic Retinopathy Study
(ETDRS) protocol.
Stereoscopic pairs of fields were obtained using a 30°
fundus camera to classify levels 20 and 35 of Wisconsin
grading, but only field 2 was used to examine and corre-
late with other data (leakage and thickness).
Fundus Fluorescein Angiography (FFA)
Fluorescein angiography was performed using a fundus cam-
era with a 45° field after patients received an injection of
fluorescein sodium, 14 mg/kg of body weight. Early- and
late-phase (5 minutes) studies were analyzed.
Retinal Leakage Analyzer
The RLA is a new method that quantifies localized fluo-
rescein leakage in humans from the retina into the vitre-
ous across the BRB. The instrumentation and all the
image processing have been previously described.4
The RLA obtains images of the fundus with real 3-di-
mensional information. Two types of information are ob-
tained simultaneously, one for optical imaging and one rep-
resenting fluorescence measurements being scanned. Axial
graphics of the fluorescein measurements obtained from
the vitreous representing a volume of 75752550 µm
were converted into retinal leakage maps. Multiple mea-
surements of retinal leakage can be graphically assembled
in a false-color retinal leakage map that represents the dis-
tribution of alterations in the BRB in any chosen area of
the total area of the posterior pole under examination. In-
travisit and intervisit reproducibility values of the method
are ±10.2% and ±13%, respectively.4
Retinal Thickness Analyzer
The RTA is a quantitative and reproducible method for evalu-
ating retinal thickness.6 The system acquires optical images
of the retina in sections by projecting the laser into the retina
at an angle, allowing the reflection or scattering of the laser
light from the vitreoretinal and chorioretinal interfaces to be
viewed. The separation between the reflections (and scat-
ter) from these 2 interfaces is a measure of retinal thickness.
The data are analyzed, and the retinal thickness is given as a
numerical value and a color-coded map.
Data Analysis
Data from the group of individuals with diabetes were com-
pared with those from a healthy control population (N=14;
mean age, 48 years; age range, 42-55 years) to establish ref-
erence maps for the RLA and RTA.5
Because of the differences in resolution between the
2 instruments (RLA and RTA), a value of leakage is ob-
tained for a 7575-µm area, while a single value of thick-
ness covers a 200200-µm area. Therefore, the smallest
area that can be constructed that contains an integer num-
ber of leakage and thickness values is 600600 µm, that
is, 88 values of leakage and 33 values of thickness.
To compare information from the RLA and RTA and
to use the more detailed data from the leakage maps, we
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values and changes in percentage of abnormal fluores-
cein leakage, either between baseline and the 6- and 12-
month examinations or between the 6- and 12-month ex-
aminations.
When comparing the RLA-leaking sites among the
3 examinations, there was good correlation between the
location of these sites of maximum leakage but a clear
fluctuation in the percentage increases (Figure 1 and
Figure 2). In total, the eyes examined showed 51 dif-
ferent RLA-leaking sites unrelated to microaneurysms or
other apparently identifiable vascular abnormalities. These
RLA-leaking sites showed the larger percentage in-
creases in fluorescein leakage. Of 51 RLA-leaking sites,
34 were identified in the same location in the retina in
subsequent examinations. Clear fluctuation in the per-
centages of abnormal fluorescein leakage between the sub-
sequent examinations was observed in 8 of the 12 eyes
examined. The other 4 eyes showed a progressive de-
crease in fluorescein leakage in the subsequent exami-
nations.
There were also 29 microaneurysms in field 2 of
the 12 eyes examined. They remained in the same loca-
tion during the 1-year follow-up period. Although asso-
ciated with some degree of abnormal fluorescein leak-
age, the percentage increases in fluorescein leakage
were relatively low (Figures 1 and 2). Furthermore,
they were found to leak progressively less in successive
examinations. Only 5 of the 29 microaneurysms showed
some increase in fluorescein leakage at the 12-month
examination.
chose 300300-µm areas. The maps are, therefore, com-
posed of 63 (97) values, each representing a 300300-µm
area, for a total of 27002100 µm.
For each 300300-µm area, the value of leakage is
the mean and SD of 16 (44) values.
To obtain a value of thickness for an equivalent
300300-µm area, we performed a 2-step procedure. First,
values of thickness were computed as the mean and SD of
9 (33) values, corresponding to a 600600-µm area. Af-
terward, this area was split into 4 adjacent 300300-µm
areas, and the mean and SD values obtained for the
600600-µm area were given to each of these 4 adjacent
areas.
In the healthy control population, the mean values
of the 63 mean values of leakage and thickness are
21.2910 −7 cm/s and 168.13 µm, respectively; for the
SD, the mean values are 6.1910−7 cm/s and 22.56 µm,
respectively. The relatively large SD for leakage, regis-
tered after averaging 14 normal retinal leakage maps, is
expected considering the high resolution of the system
associated with regional variations in vascular distribu-
tion.
By comparing values from the patients with those from
the controls, we can compute maps of increased leakage
or increased thickness as percentages.
All of the increases are computed considering the ref-
erence mean plus 2 SDs of the healthy control population.
An extended description of the data analysis meth-
ods is available elsewhere.4,5
Correlations between percentages of increases in RLA
and RTA values occurring between examinations and HbA1c
values and systolic and diastolic blood pressure measure-
ments were performed using the 2 test to compare pro-
portions.
Characterization of the Fundus Lesions
The fundus lesions are first characterized by grading each
eye based on images from 7-field SFP and using ETDRS
protocols.
Only eyes showing levels 20 and 35 of Wisconsin grad-
ing were included in this study. Combined information is
obtained only from field 2, using color SFP; FFA, early and
late phases; scanning laser ophthalmoscope angiography;
RLA; and RTA.
The alterations registered in field 2 with the different
methods used were as follows.
Stereoscopic Fundus Photography. Red dots and yellow-
ish white deposits.
Fundus Fluorescein Angiography. Early phase: outline of
the foveal avascular zone, hyperfluorescent (bright) spots,
and hypofluorescent (dark) spots; and late phase: leaking
spots (spots surrounded by diffuse hyperfluorescence).
Scanning Laser Ophthalmoscope Fluorescein Angiogra-
phy (Only Late Phase). Leaking spots.
Retinal Leakage Analyzer. Areas of increased fluorescein
leakage (300300 µm) are areas where fluorescein leakage
is more than a reference made equal to the mean plus 2 SDs
of a healthy control population. The increase is expressed as
a percentage over the reference. Retinal leakage analyzer–
leaking sites are identified as the central sites (300300 µm)
of maximum percentage of increased leakage occurring in each
area. In many cases, there is continuity between areas of in-
creased fluorescein leakage. Still, it is possible to determine
these RLA-leaking sites, checking for the first- and second-
order derivatives of the leakage map.
Retinal Thickness Analyzer. Localized measurements of
retinal thickness are obtained from a 200200-µm area.
The findings on fundus photographs and fluorescein an-
giograms were registered by 3 different observers (C.L.L.,
J.R.F.A., and J.G.C.-V.) in an independent manner. Dis-
agreements were resolved after joint examination. Defini-
tions for the lesions used in the text followed ETDRS defi-
nitions.
Only eyes that showed no capillary closure during the
early phase of the fluorescein angiogram were included in
the study analysis. Absence of capillary closure was ac-
cepted when a smooth and symmetrical outline of the fo-
veal avascular zone was observed, with defects no larger
than 10% of the entire outline.
To interpret the data, the following definitions, co-
inciding largely with ETDRS definitions, were used: micro-
aneurysms, isolated red dots in SFP images that coincide with
hyperfluorescent spots in the early FFA; hemorrhages, round
or linear red spots in SFP images that do not fluoresce on
FFA or that appear as dark spots in FFA images; drusen, deeply
located yellowish white deposits in the SFP image that be-
came hyperfluorescent in early FFA; and hard exudates, white
or yellow-white deposits that do not fluoresce or that ap-
pear as dark spots in FFA images.
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Increases in retinal thickness were also detected in
all eyes examined at 1 of the 3 examinations performed
in each eye. The sites of maximum percentage thickness
were generally lower than 30% above normal values, with
the sole exception of the last examination of patient 10.
Changes were found between the location of sites of
maximum percentage increase in retinal thickness when
comparing examinations performed in the same eye in 7
of the 12 eyes. The 5 eyes that had a more stable abnormal
increase in retinal thickness also showed involvement of
the fovea and had higher maximum percentage increases
in retinal thickness. The changes in retinal thickness showed
no statistical correlation with changes in HbA1c values or
with systolic or diastolic blood pressure values. Finally, a
correlation was observed between the location of the RLA-
leaking sites represented by sites of maximum percentage
of increased fluorescein leakage at one examination and the
location of sites of maximum percentage increase in reti-
nal thickness in subsequent examinations, either 6 or 12
months later (Figures 1 and 2).
The coincidence between the location of sites of in-
creased thickness and RLA-leaking sites in previous ex-
aminations was 61% for the 6-month examination and
71% for the 12-month examination.
COMMENT
Our method of multimodal imaging of the ocular fun-
dus allows correlations to be established between fun-












Leakage, % Thickness, %
Area‡ Maximum§ Area‡ Maximum§
1/Right/60 3 6.7 160/90 35 4 84 67 79 20
7.0 160/85 35 4 8 30 0 0
6.2 155/80 35 4 3 10 13 11
2/Left/44 6 7.9 160/90 35 3 100 483 14 2
7.4 160/90 35 3 66 62 0 0
7.5 160/90 35 3 70 90 41 11
3/Right/53 7 9.4 140/80 35 4 57 72 10 4
9.5 150/90 35 4 70 61 0 0
8.5 150/85 35 4 0 0 33 13
4/Left/54 10 6.3 110/70 35 1 33 50 29 12
7.8 120/65 20 1 5 30 93 23
6.7 120/70 20 1 4 15 86 25
5/Left/55 10 6.9 160/85 20 0 5 3 43 14
7.4 160/90 20 0 0 0 27 11
7.5 160/85 20 0 14 40 25 3
6/Right/60 9 8.6 130/70 20 1 20 27 0 0
9.7 135/75 20 1 0 0 44 10
8.5 120/60 20 1 0 0 44 9
7/Left/50 10 7.6 125/80 20 2 100 175 48 13
8.3 155/90 35 2 21 29 4 1
9.3 140/90 20 2 100 250 0 0
8/Right/54 2 5.4 130/80 20 3 31 27 0 0
5.4 120/80 20 3 0 0 17 9
5.6 130/80 20 3 0 0 0 0
9/Left/63 4 6.6 140/75 20 4 9 29 7 1
6.3 140/60 20 4 2 10 63 21
5.9 130/70 20 4 0 0 46 27
10/Right/51 15 8.4 145/90 20 3 67 72 48 14
7.8 155/85 20 3 0 0 62 18
8.0 130/80 20 3 83 83 68 34
11/Left/56 9 6.9 120/70 20 1 76 120 16 10
7.3 160/90 20 1 100 129 86 31
7.0 120/70 20 1 0 0 100 24
12/Left/56 12 9.4 150/90 20 3 41 47 93 26
9.0 160/90 20 3 0 0 100 29
9.5 170/95 20 3 30 41 64 21
Minimum / . . . / 44 2 5.4 . . . . . . . . . 0 0 0 0
Mean / . . . / 55 8 7.6 . . . . . . . . . 33 57 39 12
Maximum / . . . / 63 15 9.7 . . . . . . . . . 100 483 100 34
SD / . . . / 5 4 1.2 . . . . . . . . . 37 91 33 10
*Data are given as values at baseline and at the 6- and 12-month examinations, respectively, unless otherwise indicated. HbA1c indicates hemoglobin A1c;
BP, blood pressure; MA, number of microaneurysms; and ellipses, data not applicable.
†Values are given as the percentage of total hemoglobin.
‡Values indicate the percentage of altered area (any increase of leakage or thickness over the reference) of leakage or thickness relative to the total scanned
area for that eye.
§Data indicate the maximum value of increase over the reference that occurred in that eye.
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mapping fluorescein leakage into the vitreous, and changes
in retinal thickness. Previous studies5,7 have shown in the
macular region of patients with type 2 diabetes mellitus
and nonproliferative retinopathy, in most eyes exam-
ined, that localized sites of increased fluorescein leak-
age did not show good correlation with the zones of in-
creased retinal thickness. To explain this apparent lack
of correlation between sites of alteration of the BRB and
zones of retinal edema in the diabetic macula, the pres-
ence of 2 types of edema, vasogenic and cytotoxic, was
put forward.5,7 There is a need for studies of the natural
history of these alterations occurring in the early stages
of diabetic retinal disease using these new methods and
performed in a prospective fashion.
In the present study, a 1-year follow-up of patients
with type 2 diabetes mellitus and mild nonproliferative
retinopathy, we performed 3 examinations, at baseline
and 6 and 12 months later.
The most frequent alterations observed were, in de-
creasing order of frequency, RLA-leaking sites, areas of
increased retinal thickness, microaneurysms, and dru-
sen. Hemorrhages and hard exudates were relatively rare
in the macular region (photographic field 2 of the ETDRS)
in these eyes with mild nonproliferative diabetic reti-
nopathy (levels 20 and 35 of Wisconsin grading).
Retinal leakage analyzer–leaking sites reached per-
meability indexes of the BRB as high as 483% above nor-
mal. These sites of alteration of the BRB, well identified
in the RLA maps, varied little in their location on suc-
cessive examinations at 6-month intervals, but their BRB
permeability indexes fluctuated greatly when compar-
ing subsequent examinations. In 10 of the 36 examina-
tions, RLA maps returned to normal levels. Most of the
RLA-leaking sites were not associated with any visible
morphologic alteration of the retina, such as microan-
eurysms, hemorrhages, or other vascular abnormalities.
The intensity of fluorescein leakage, represented by
the BRB permeability indexes in these RLA-leaking sites,
correlated well with the changes in HbA1c levels, when
comparing the 6- and 12-month examinations. De-
creases in HbA1c levels, indicating improved metabolic
control, were associated with decreasing fluorescein leak-
age, and increases in HbA1c levels with increasing fluo-
rescein leakage. No correlation was found, however, be-
tween variations in fluorescein leakage and blood pressure































































































































Figure 1. Integrated maps of patient 10, including data from stereoscopic
fundus photography (black lines and red dots), the retinal leakage analyzer
(RLA) (color-coded maps of blood-retinal barrier permeability indexes), and
the retinal thickness analyzer (RTA) (white dot density maps of percentage
increases in retinal thickness) obtained from visits at baseline (A), 6 months










Figure 2. Integrated information for patient 10 for the 3 visits (at 0, 3, and 6
months). Each square represents data from a 300300-µm area in the
fundus. The 2 black dots show the location of 2 microaneurysms that were
present at the 3 visits. An abnormal increase in thickness at the first visit is
shown as shaded squares; at the second visit, as 45° lines (/); and at the
third visit, as 135° lines (\). For an abnormal increase in leakage, only the
central retinal leakage analyzer (RLA)–leaking sites are shown. The numbers
inside the circles represent the percentage of increase over the reference
map for the first visit. For the second and third visits, the value is shown
inside squares (none for this patient) and inside diamonds, respectively.
Note the location of the RLA-leaking sites and their fluctuation during the
1-year period. There are 3 leaking sites common to the first and third visits.
All of them decreased to within normal values at the second visit and showed
important increases at the third visit, thus clearly demonstrating fluctuation
in the percentage of fluorescein sodium leakage at these leaking sites. The
small circle in the center of each map denotes the location of the center of
the fovea; the large circle, centered on the fovea, denotes a circle of 1500 µm
in diameter; and the black curvy lines, retinal vessels.
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cause of the small number of patients involved and the
fact that the blood pressure levels remained relatively
stable during the study, in each patient. These findings
confirmed and expanded previous reports using slit-
lamp vitreous fluorometry8 and vitreous fluorometry,9
showing that an increase in permeability of the BRB to
fluorescein is an early finding in patients with diabetic
retinal disease.10,11 The RLA, based on scanning laser oph-
thalmoscope methods, goes a step further by identify-
ing the actual sites of increased fluorescein leakage.
A particularly interesting observation in this study
is the widespread presence of increased retinal thick-
ness, ie, retinal edema. Our findings offer some insight
into the mechanisms of development of retinal edema in
the initial stages of diabetic retinopathy. The location of
RLA-leaking sites appears to be predictive of the later de-
velopment in the same location of areas of increased reti-
nal thickness. An alteration of the BRB appears, there-
fore, to be associated with the development of diabetic
retinal edema, at least in this stage of retinopathy.
Another interesting observation was the variation
found between subsequent examinations in the loca-
tion and extent of the areas of increased retinal thick-
ness. These variations give support to the view that the
retinal edema observed in these eyes is extracellular and
not intracellular. We have, therefore, retinal edema that
fulfills the criteria for being classified as vasogenic edema,
that is, it is associated with an alteration of the BRB and
appears to be predominantly extracellular. This fol-
low-up study, allowing comparisons to be made be-
tween 3 subsequent examinations, performed at 6-month
intervals, indicates that vasogenic edema is the predomi-
nant type of retinal edema occurring in these initial stages
of nonproliferative diabetic retinopathy.
The extent and percentage increases in retinal thick-
ness did not show any clear correlation with HbA1c lev-
els or blood pressure variations. They appeared, how-
ever, to be a late result of an alteration of the BRB identified
in previous examinations.
Longer follow-up studies are, therefore, needed to
examine relationships between the occurrence of reti-
nal edema and changes in metabolic control or blood pres-
sure levels.
During the 1-year follow-up period, microaneuryms
leaked progressively less at successive examinations. This
observation suggests that these vascular lesions are in the
process of progressive occlusion and gives support to the
view that they are sites of localized thrombosis.12
In conclusion, our observations suggest that the
dominant alteration in the retina of patients with type 2
diabetes mellitus and mild nonproliferative retinopathy
is the presence of RLA-leaking sites, indicating spotty
retinal vascular damage characterized by alteration of
the BRB. This spotty retinal vascular damage appears to
be reversible and directly associated with variations in
metabolic glycemic control. These findings offer particu-
larly exciting perspectives for medical therapy of dia-
betic retinopathy.
The methods of examination we used could not
show, however, if these leaking sites are associated with
or preceded by dynamic changes in the retinal vascula-
ture, such as localized vasodilation or vasoconstriction.
Retinal edema, also a frequent finding, appears to
develop as a result of retinal vascular leakage.
Longer follow-up studies, using new methods of ex-
amination, such as the RLA and the RTA, ideally com-
bined with blood flow studies at the capillary level, in-
tegrated in multimodal imaging of the ocular fundus, are
expected to clarify many of the remaining questions.
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